Skip to content

Opening book details…

About this Medicine article

370 AJM300, an oral a4 integrin antagonist, for active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled phase 2a study by Watanabe, Mamoru; Yoshimura, Naoki; Motoya, Satoshi; Tominaga, Keiichi; Iwakiri, Ryuichi; Watanabe, Kenji; Hibi, Toshifumi is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Watanabe, Mamoru; Yoshimura, Naoki; Motoya, Satoshi; Tominaga, Keiichi; Iwakiri, Ryuichi; Watanabe, Kenji; Hibi, Toshifumi
Publisher
Elsevier Science; Elsevier ; Mosby Inc.; Elsevier BV (ISSN 1097-6779)
Published
2014
Language
EN
Field
Medicine (Health Sciences)

More by Watanabe, Mamoru; Yoshimura, Naoki; Motoya, Satoshi; Tominaga, Keiichi; Iwakiri, Ryuichi; Watanabe, Kenji; Hibi, Toshifumi

Browse all works by Watanabe, Mamoru; Yoshimura, Naoki; Motoya, Satoshi; Tominaga, Keiichi; Iwakiri, Ryuichi; Watanabe, Kenji; Hibi, Toshifumi